11/15
06:50 am
derm
Despite Journey Medical's Pullback, Insiders Still Gained US$118k [Yahoo! Finance]
Medium
Report
Despite Journey Medical's Pullback, Insiders Still Gained US$118k [Yahoo! Finance]
11/12
04:12 pm
derm
Journey Medical Corporation Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights [Yahoo! Finance]
High
Report
Journey Medical Corporation Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights [Yahoo! Finance]
11/12
04:01 pm
derm
Journey Medical Corporation Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights
Medium
Report
Journey Medical Corporation Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights
11/4
08:42 am
derm
Journey Medical (DERM) Soars 7.3%: Is Further Upside Left in the Stock? [Yahoo! Finance]
High
Report
Journey Medical (DERM) Soars 7.3%: Is Further Upside Left in the Stock? [Yahoo! Finance]
11/4
07:00 am
derm
Journey Medical Corporation Announces U.S. FDA Approval of Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the Treatment of Rosacea
High
Report
Journey Medical Corporation Announces U.S. FDA Approval of Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the Treatment of Rosacea
10/25
08:30 am
derm
Journey Medical Corporation Announces DFD-29 Data Presented at 44th Fall Clinical Dermatology Conference
High
Report
Journey Medical Corporation Announces DFD-29 Data Presented at 44th Fall Clinical Dermatology Conference
10/3
08:30 am
derm
Journey Medical Corporation to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference
Medium
Report
Journey Medical Corporation to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference
9/28
08:32 am
derm
Can Journey Medical Corporation (NASDAQ:DERM) Improve Its Returns? [Yahoo! Finance]
Low
Report
Can Journey Medical Corporation (NASDAQ:DERM) Improve Its Returns? [Yahoo! Finance]
9/9
08:30 am
derm
Journey Medical Corporation to Participate in the Lake Street Capital Markets 8th Annual Best Ideas Growth (BIG) Conference
Low
Report
Journey Medical Corporation to Participate in the Lake Street Capital Markets 8th Annual Best Ideas Growth (BIG) Conference
9/6
10:03 am
derm
Journey Medical Co. (NASDAQ: DERM) is now covered by analysts at Lake Street Capital. They set a "buy" rating and a $9.00 price target on the stock.
Medium
Report
Journey Medical Co. (NASDAQ: DERM) is now covered by analysts at Lake Street Capital. They set a "buy" rating and a $9.00 price target on the stock.
9/4
08:15 am
derm
Journey Medical Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Low
Report
Journey Medical Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference